medigraphic.com
ISSN 0210-5187 (Electronic)

2004, Number 4

<< Back Next >>

Med Cutan Iber Lat Am 2004; 32 (4)

Management of Diabetic Skin Wounds with a Natural Latex Biomembrane

Cipriani FMA, Brum CI, Fortes AF, Coutinho NJ, Magalhães BF, Tiraboschi FN

Language: English
References: 15
Page: 157-162
PDF size: 702.35 Kb.


Text Extraction

The natural latex biomembrane (NLB) is an alternative dressing used to treat skin wounds, with activities that increase the healing process. The authors report the results obtained with the NLB dressing for chronic skin wounds of different etiologies with impaired healing affecting four diabetic patients. The NLB was found to act as an economic, easily handled and highly effective dressing, mainly because of its debriding potential and its angiogenicity, permitting a dynamic and fast healing process essential for wound healing in diabetic patients.


REFERENCES

  1. Mrué F. Neoformação tecidual induzida por biomembrana de látex natural com polilisina. Doctoral thesis. FMRP-USP, 2000.

  2. Frade MAC. Úlcera de perna: caracterização clínica e perfil imunohistopatológico da cicatrização na presença da biomembrana de látex natural da seringueira Hevea brasiliensis. Doctoral thesis. FMRP-USP, 2003.

  3. Frade MAC, Valverde RV, Assis RVC, Coutinho-Netto J, et al. Chronic phlebopathic cutaneous ulcer: a therapeutic proposal. Int J Dermatol 2001; 40: 237-40.

  4. Marble A, Krall LP, Bradley RF, Christlieb AR, et al. In: Diabetes mellitus. 12th edn. Lea-Febiger, Philadelphia, 526-52, 1985.

  5. Eisenbarch GS. Type 1 diabetes mellitus. A chronic autoimmune disease. N Engl J Med 1986; 314: 1360-8.

  6. De Fonzo RA, Ferrannini E. Insulin resistance. A multifaceted syndrome responsible for type 2 diabetes mellitus, obesity, hypertension, dyslipidemic and atherosclerotic cardiovascular disease. Diabetes Care 1991; 14: 173.

  7. Diabetes Mellitus. Fitzpatrick’s Dermatology in General Medicine. In: 5th ed. McGraw Hill. 1999; 169: 1969-75.

  8. Bonham PA. Assessment and management of patients with venous, arterial, and diabetic/neuropathic lower extremity wounds. AACN Clin Issues 2003; 14:442-56.

  9. Spravchikov N, Sizyakov G, Gartsbein M, Accili D, et al. Glucose effects on skin keratinocytes: implications for diabetes skin complications. Diabetes 2001; 50: 1627-35.

  10. Chang K, Uitto J, Rowold EA, Grant GA, Kilo C, Williamson JR. Increased cross linkages in experimental diabetes. Diabetes 1980;29:778.

  11. Klingbeil CK, Cesar LB, Fiddes JC.Basic fibroblast growth factor accelerates tissue repair in models of impaired wound healing. Prog Clin Biol Res 1991; 365:443-458.

  12. Broadley KN, Aquino AM, Hicks B, Ditesheim JA, McGee GS, Demetriou AA, Woodward SC, Davidson JM.The diabetic rat as an impaired wound healing model:Stimulatory effects of TGFbeta - BFGF.Biotechonol Ther 1989;1:55-68.

  13. Bennett SP, Griffiths GD, Schor AM, Leese GP, Schor SL. Growth factors in the treatment of diabetic foot ulcers. Br J Surg 2003;90:133-146.

  14. Frade MAC, Lamounier FMC, Carvalho MTF, Coutinho-Netto J, Foss NT. Biomembrana de Látex 0,1 de seringueira hevea brasiliensis: Uma nova opção terapêutica na Cirurgia Oncológica. Anais do XII Cong Bras Cir Derm. S. Paulo-(CD-ROM), 2000.

  15. Frade MAC, Cursi IB, Andrade FF, Coutinho-Netto J, Foss NT. Induction of leg wound healing by natural latex biomembrane (NLB). Annales de Dermatologie et de Vénéréologie (20th World Congress of Dermatology), Paris, 2002 p. 1S823.




2020     |     www.medigraphic.com